Patent: 9,393,307
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 9,393,307
Title: | Caspofungin composition |
Abstract: | The present invention relates to a composition comprising caspofungin or a pharmaceutical acceptable salt thereof and succinate or lactate as a buffering agent. |
Inventor(s): | Shirode; Swapnil P. (Masharashtra, IN), Patel; Piyush (Maharashtra, IN), Gidwani; Suresh (Mumbai, IN), Parikh; Neil (Irvine, CA), Patil; Atul (Maharashtra, IN), Mochnik; Anita Bevetek (Sesvetski Kraljevec, HR) |
Assignee: | XELLIA PHARMACEUTICALS APS (Kobenhaven, DK) |
Application Number: | 14/547,742 |
Patent Claims: | see list of patent claims |
Details for Patent 9,393,307
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | ZOSTAVAX | zoster vaccine live | For Injection | 125123 | 05/25/2006 | ⤷ Try a Trial | 2030-09-20 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |